Goldman Sachs Group Inc Bio Xcel Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.14 - $2.97 $86,864 - $226,305	76,197 Added 334.64%	98,967 $126,000
Q1 2024 May 15, 2024	BUY	$1.95 - $4.04 $6,961 - $14,422	3,570 Added 18.59%	22,770 $64,000
Q4 2023 Feb 13, 2024	SELL	$2.32 - $5.51 $263,723 - $626,343	-113,674 Reduced 85.55%	19,200 $56,000
Q3 2023 May 14, 2024	BUY	$2.49 - $11.85 $283,048 - $1.35 Million	113,674 Added 592.05%	132,874 $336,000
Q3 2023 Nov 14, 2023	SELL	$2.49 - $11.85 $27,818 - $132,388	-11,172 Reduced 7.76%	132,874 $336,000
Q2 2023 May 14, 2024	SELL	$6.39 - $28.58 $125,269 - $560,282	-19,604 Reduced 11.98%	144,046 $959,000
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $125,269 - $560,282	-19,604 Reduced 11.98%	144,046 $959,000
Q1 2023 May 14, 2024	BUY	$17.7 - $33.24 $1.95 Million - $3.66 Million	110,226 Added 206.32%	163,650 $3.05 Million
Q1 2023 May 11, 2023	BUY	$17.7 - $33.24 $1.95 Million - $3.66 Million	110,226 Added 206.32%	163,650 $3.05 Million
Q4 2022 May 14, 2024	SELL	$10.25 - $22.43 $410,871 - $899,106	-40,085 Reduced 42.87%	53,424 $1.15 Million
Q4 2022 Feb 13, 2023	SELL	$10.25 - $22.43 $410,871 - $899,106	-40,085 Reduced 42.87%	53,424 $1.15 Million
Q3 2022 May 14, 2024	BUY	$11.19 - $17.89 $233,143 - $372,738	20,835 Added 28.67%	93,509 $1.11 Million
Q3 2022 Nov 10, 2022	BUY	$11.19 - $17.89 $233,143 - $372,738	20,835 Added 28.67%	93,509 $1.11 Million
Q2 2022 May 14, 2024	BUY	$9.03 - $21.55 $482,870 - $1.15 Million	53,474 Added 278.51%	72,674 $959,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $35,451 - $84,605	3,926 Added 5.71%	72,674 $959,000
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $285,210 - $434,089	19,014 Added 38.23%	68,748 $1.44 Million
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $276,951 - $483,013	13,765 Added 38.27%	49,734 $1.01 Million
Q3 2021 Nov 10, 2021	BUY	$23.84 - $32.03 $857,500 - $1.15 Million	35,969 New	35,969 $1.09 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account